The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF).

Authors	Tor Biering-Sørensen, Masatoshi Minamisawa, Jiankang Liu, Brian Claggett, Alexander I Papolos, G Michael Felker, John J V McMurray, Jason C Legg, Fady I Malik, Narimon Honarpour, Christopher E Kurtz, John R Teerlink, Scott D Solomon
Journal	European journal of heart failure (Eur J Heart Fail) Vol. 23 Issue 6 Pg. 1052-1056 (06 2021) ISSN: 1879-0844 [Electronic] England
PMID	33826209 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References	omecamtiv mecarbil Urea Cardiac Myosins
Topics	Cardiac Myosins Heart Failure (drug therapy) Heart Failure, Systolic (drug therapy) Humans Stroke Volume Urea (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!